Yaniv Berger

University of Chicago

Papers

2

Total Citations

76

H-Index

2

About

Yaniv Berger is a leading surgical oncologist whose research focuses on improving outcomes in complex pancreatic surgery, particularly through the comparison of robotic and open surgical techniques. His major contributions center on demonstrating the safety and efficacy of robotic pancreaticoduodenectomy (RPD) over traditional open pancreaticoduodenectomy (OPD). In his highly cited 2020 NSQIP analysis with propensity score matching, Berger identified key risk factors for complications, showing that RPD significantly reduces the risk of clinically relevant post-operative pancreatic fistula—a life-threatening complication. His work, which has garnered over 76 citations across his top papers, provides robust evidence supporting the adoption of minimally invasive approaches in high-risk patients. Berger’s research is notable for its rigorous methodology, using large national databases to control for selection bias, and has directly influenced surgical guidelines and practice. By quantifying the benefits of robotic surgery, he has helped pave the way for safer, less invasive pancreatic resections, making his findings essential reading for surgeons and trainees aiming to optimize patient outcomes in hepatopancreatobiliary surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
76
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Risk factors for complications in patients undergoing pancreaticoduodenectomy: A NSQIP analysis with propensity score matching
40 citations · 2020
📈 Most Prolific Year: 2020 (2 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: University of Chicago

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago